APA (7th ed.) Citation

Gnanapragasam, V., Barret, T., Starling, L., George, A., Burling, K., Saeb-Parsy, K., . . . Kim, L. (2019). 100 - Use of the PHI assay as a first line triaging test in an image-guided prostate cancer diagnostic pathway. The PHI in Refining MRI (PRIM) study. European Urology Supplements, 18(1), e129. https://doi.org/10.1016/S1569-9056(19)30099-5

Chicago Style (17th ed.) Citation

Gnanapragasam, V.J, T. Barret, L. Starling, A. George, K. Burling, K. Saeb-Parsy, C. Kastner, B. Lamb, and L. Kim. "100 - Use of the PHI Assay as a First Line Triaging Test in an Image-guided Prostate Cancer Diagnostic Pathway. The PHI in Refining MRI (PRIM) Study." European Urology Supplements 18, no. 1 (2019): e129. https://doi.org/10.1016/S1569-9056(19)30099-5.

MLA (9th ed.) Citation

Gnanapragasam, V.J, et al. "100 - Use of the PHI Assay as a First Line Triaging Test in an Image-guided Prostate Cancer Diagnostic Pathway. The PHI in Refining MRI (PRIM) Study." European Urology Supplements, vol. 18, no. 1, 2019, p. e129, https://doi.org/10.1016/S1569-9056(19)30099-5.